SEC 13F Intelligence

Parkman Healthcare Partners LLC / XENE

Parkman Healthcare Partners LLC’s Xenon Pharmaceuticals Inc Position

Does Parkman Healthcare Partners LLC own Xenon Pharmaceuticals Inc (XENE)? Yes — 497.0K shares worth $29M (+2.98% of its 13F portfolio) as of Q1 2026, up from 154.2K shares the prior filed quarter.

Position Value
$29M
Q1 2026
Shares
497.0K
% of Portfolio
+2.98%
Quarters Held
26
currently held

Position History XENE

Reported value by quarter
Q4 ’19: $8MQ4 ’19Q1 ’20: $7MQ2 ’20: $7MQ3 ’20: $5MQ4 ’20: $6MQ4 ’20Q1 ’21: $7MQ2 ’21: $7MQ3 ’21: $5MQ4 ’21: $11MQ4 ’21Q1 ’22: $9MQ2 ’22: $9MQ3 ’22: $8MQ4 ’22: $9MQ4 ’22Q1 ’23: $10MQ2 ’23: $8MQ3 ’23: $7MQ4 ’23: $14MQ4 ’23Q1 ’24: $10MQ2 ’24: $8MQ3 ’24: $8MQ4 ’24: $8MQ4 ’24Q1 ’25: $6MQ2 ’25: $5MQ3 ’25: $7MQ4 ’25: $7MQ4 ’25Q1 ’26: $29Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026497.0K$29M+2.98%
Q4 2025154.2K$7M+0.66%
Q3 2025176.1K$7M+0.74%
Q2 2025150.4K$5M+0.54%
Q1 2025174.6K$6M+0.69%
Q4 2024193.0K$8M+1.01%
Q3 2024191.7K$8M+0.96%
Q2 2024209.3K$8M+1.09%
Q1 2024223.9K$10M+1.18%
Q4 2023294.8K$14M+1.91%
Q3 2023216.6K$7M+1.36%
Q2 2023217.7K$8M+1.45%
Q1 2023277.3K$10M+2.16%
Q4 2022235.5K$9M+2.47%
Q3 2022222.6K$8M+2.28%
Q2 2022294.6K$9M+3.30%
Q1 2022304.2K$9M+2.72%
Q4 2021360.5K$11M+2.49%
Q3 2021311.2K$5M+1.20%
Q2 2021401.2K$7M+1.63%
Q1 2021374.4K$7M+1.56%
Q4 2020361.7K$6M+1.43%
Q3 2020464.8K$5M+1.36%
Q2 2020590.3K$7M+2.09%
Q1 2020590.3K$7M+3.10%
Q4 2019588.1K$8M+2.23%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Parkman Healthcare Partners LLC’s full portfolio or all institutional holders of XENE.